Galectin Therapeutics (GALT) files mixed shelf
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mail
Get Alerts GALT Hot Sheet
Join SI Premium – FREE
Galectin Therapeutics (NASDAQ: GALT) has filed mixed shelf of:
Common Stock
Warrants
Rights
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Zura Bio (ZURA) files $700M mixed shelf
- Bluesky Digital director Frank Kordy departs board
- SK Hynix (SKHY) 3q Oper Profit 83.33t Won, Est. 77.5t Won - Bloomberg
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
